Black Rock Inc. X4 Pharmaceuticals, Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Black Rock Inc. holds 10,675,963 shares of XFOR stock, worth $27.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,675,963

Previous 8,735,867 22.21%

Holding current value

$27.5 Million

Previous $12.1 Million 49.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.58 - $1.47 $1.13 Million - $2.85 Million	1,940,096 Added 22.21%	10,675,963 $6.19 Million
Q1 2024 May 10, 2024	BUY	$0.72 - $1.46 $229,206 - $464,780	318,343 Added 3.78%	8,735,867 $12.1 Million
Q4 2023 Feb 13, 2024	BUY	$0.61 - $0.99 $159,016 - $258,076	260,683 Added 3.2%	8,417,524 $7.07 Million
Q3 2023 Nov 13, 2023	SELL	$1.03 - $2.02 $966,585 - $1.9 Million	-938,433 Reduced 10.32%	8,156,841 $8.89 Million
Q2 2023 Aug 11, 2023	BUY	$0.82 - $2.49 $7.18 Million - $21.8 Million	8,751,694 Added 2547.21%	9,095,274 $17.6 Million
Q1 2023 May 12, 2023	BUY	$0.8 - $1.22 $55,115 - $84,050	68,894 Added 25.08%	343,580 $298,000
Q4 2022 Feb 13, 2023	SELL	$0.69 - $2.21 $10,140 - $32,480	-14,697 Reduced 5.08%	274,686 $271,000
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.71 $10,617 - $20,400	11,930 Added 4.3%	289,383 $494,000
Q2 2022 Aug 12, 2022	BUY	$0.88 - $1.91 $4,979 - $10,808	5,659 Added 2.08%	277,453 $268,000
Q1 2022 May 12, 2022	SELL	$1.48 - $2.58 $4,075 - $7,105	-2,754 Reduced 1.0%	271,794 $476,000
Q4 2021 Feb 10, 2022	BUY	$1.9 - $5.6 $11,586 - $34,148	6,098 Added 2.27%	274,548 $628,000
Q3 2021 Nov 09, 2021	BUY	$4.53 - $6.45 $23,374 - $33,282	5,160 Added 1.96%	268,450 $1.42 Million
Q2 2021 Aug 11, 2021	BUY	$6.49 - $9.56 $1.71 Million - $2.52 Million	263,290 New	263,290 $1.71 Million

Others Institutions Holding XFOR

# of Institutions

Shares Held

14.5M

Call Options Held

Put Options Held

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $177M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account